Sean Parker finds a big role to play in cancer R&D: The disruptive billionaire
In biotech, where everything is uncertain, execs like to be as predictable as possible. Scripts are maintained, nasty surprises are avoided whenever possible and speed is fine, so long as you stick to your schedule and don’t look like you’re in too much of a hurry.
And then there’s Sean Parker. Parker had an easy role to play as the billionaire founder of a new cancer R&D institute. The trailblazers could get a fresh source of cash and a few years from now he could claim progress on the ever-popular notion of finding a cure for cancer.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.